Dr Agnes Vitry

Dr Agnes Vitry

School of Pharmacy and Biomedical Science

College of Health

Available For Media Comment.

I am a Senior Lecturer at the School of Pharmacy and Health Sciences. My research focuses on three main areas:

- medicines policies in Australia and the Western Pacific Region: regulatory approval, funding, pricing, managed entry agreements, affordability, usage, and pharmaceutical promotion; - quality use of medicines in people with comorbidities (elderly people, people living with cancer, residents of nursing homes). - systematic reviews of trial and observational evidence on health outcomes of medicines. In the recent years, I have collaborated with numerous organisations including the Australian Government’s Department of Health (Pharmaceutical Benefits Scheme (PBS) Post-Market Reviews), the Australian Commission on Safety and Quality in Health Care, the World Health Organization Western Pacific Region (WPRO) Office, and Health Action International. I am strongly involved in the activities of consumer organisations in particular Cancer Voices SA with the development of a ‘patients as teachers’ academic program and several collaborative research projects.

Quality use of medicines,Pharmaco-epidemiology,Medicines policies, pharmaceutical regulations, transparency of medicine agencies,Quality of medicines information for health professionals and consumers, clinical guidelines,Drug promotion, quality use of medicines, conflicts of interests,Assessment of new medicines

Year Citation
2025 Menz, B. D., Modi, N. D., Abuhelwa, A. Y., Kuderer, N. M., Lyman, G. H., Swain, S. M., . . . Hopkins, A. M. (2025). Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials. International Journal of Cancer, 157(10), 2135-2145.
DOI Scopus1 Europe PMC2
2025 Modi, N. D., Abuhelwa, A. Y., Kuderer, N. M., Li, L. X., Lyman, G. H., Koczwara, B., . . . Hopkins, A. M. (2025). Associations of commonly used concomitant medications with survival and adverse event outcomes in breast cancer. Cancer Medicine, 14(21, article no. e71320), 1-10.
DOI Europe PMC1
2025 Menz, B. D., Modi, N. D., Abuhelwa, A. Y., Ruanglertboon, W., Vitry, A., Gao, Y., . . . Hopkins, A. M. (2025). Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models. European Journal of Cancer, 218, 115274-1-115274-6.
DOI Scopus11 WoS11 Europe PMC6
2024 Menz, B. D., Kuderer, N. M., Bacchi, S., Modi, N. D., Chin-Yee, B., Hu, T., . . . Hopkins, A. M. (2024). Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ, 384(e078538), e078538-1-e078538-10.
DOI Scopus64 WoS56 Europe PMC43
2024 Vitry, A., Inglis, J., & Caird, C. (2024). Evidence of clinical benefit of cancer medicines considered for funding in Australia. International Journal of Technology Assessment in Health Care, 40(1, article no. e55), 1-7.
DOI Scopus1 WoS1
2023 Gheybi, K., Buckley, E., Vitry, A., & Roder, D. (2023). Variations in colorectal cancer pattern of care by age and comorbidity in South Australia. Cancer Medicine, 12(11), 12118-12127.
DOI Scopus1 WoS1 Europe PMC1
2023 Gheybi, K., Buckley, E., Vitry, A., & Roder, D. (2023). Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer. Frontiers in Public Health, 11(1101771), 1101771-1-1101771-10.
DOI Scopus5 WoS5 Europe PMC6
2023 Mintzes, B., & Vitry, A. (2023). Australia to lose agency dedicated to better quality medicine use. Drug and therapeutics bulletin, 61(1), 2.
DOI
2022 Gheybi, K., Buckley, E., Vitry, A., & Roder, D. (2022). Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis.. Cancer Epidemiol, 80(102246), 8 pages.
DOI Scopus8 WoS8 Europe PMC8
2022 Coro, D. G., Hutchinson, A. D., Dyer, K. A., Banks, S., Koczwara, B., Corsini, N., . . . Coates, A. M. (2022). ‘Food for Thought’—The Relationship between Diet and Cognition in Breast and Colorectal Cancer Survivors: A Feasibility Study. Nutrients, 14(1), 22 pages.
DOI Scopus5 WoS5 Europe PMC4
2021 Vitry, A., Forte, G., & White, J. (2021). Access to controlled medicines in low-income countries: listening to stakeholders in the field. International Journal of Health Services, 51(3), 404-411.
DOI Scopus3 WoS3 Europe PMC3
2021 Post, D., Vitry, A., & Baldock, K. L. (2021). Evaluating changes in student health, wellbeing and social circumstances before and during COVID-19 pandemic restrictions in Australia. Peerj, 9(e12078), 10 pages.
DOI Scopus3 WoS3 Europe PMC2
2021 Vitry, A., & Mintzes, B. (2021). 'Drugs to avoid' to improve quality use of medicines: how is Australia faring?. Journal of Pharmaceutical Policy and Practice, 14(1, article no. 60), 1-9.
DOI
2021 Mintzes, B., & Vitry, A. (2021). 'Drugs to avoid': can we improve prescribing appropriateness?. Drug and Therapeutics Bulletin, 59(11), 1.
DOI
2020 Caughey, G. E., Inacio, M. C., Bell, J. S., Vitry, A. I., & Shakib, S. (2020). Inclusion of older people reflective of real-world clinical practice in cardiovascular drug trials. Journal of the American Heart Association, 9(21), e016936-1-e016936-8.
DOI Scopus16 WoS16 Europe PMC13
2020 Hillen, J. B., Vitry, A., & Caughey, G. E. (2020). Erratum: Medication-related quality of care in residential aged care: an Australian experience (International Journal for Quality in Health Care (2018) (1-9) DOI: 10.1093/intqhc/mzy164). International Journal for Quality in Health Care, 32(7), 488.
DOI WoS4 Europe PMC1
2020 Ng, H. S., Koczwara, B., Roder, D., Chan, R. J., & Vitry, A. (2020). Patterns of health service utilisation among the Australian population with cancer compared with the general population. Australian Health Review, 44(3), 470-479.
DOI Scopus9 WoS8 Europe PMC5
2019 Ng, H. S., Vitry, A., Koczwara, B., Roder, D., & McBride, M. L. (2019). Patterns of comorbidities in women with breast cancer: a Canadian population-based study. Cancer causes & control, 30(9), 931-941.
DOI Scopus47 WoS45 Europe PMC42
2019 Fabbri, A., Swandari, S., Lau, E., Vitry, A., & Mintzes, B. (2019). Pharmaceutical industry funding of health consumer groups in Australia: a cross-sectional analysis. International journal of health services, 49(2), 273-293.
DOI
2019 Mintzes, B., & Vitry, A. (2019). Flawed evidence underpins approval of new cancer drugs. BMJ, 366(l5399), 1-2.
DOI
2018 Grover, P., Babar, Z. U. D., Oehmen, R., & Vitry, A. (2018). Medicines access programs to cancer medicines in Australia and New Zealand: an exploratory study. Health policy, 122(3), 243-249.
DOI
2018 Ng, H. S., Koczwara, B., Roder, D., Niyonsenga, T., & Vitry, A. (2018). Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study. Journal of comorbidity, 8(1), 16-24.
DOI Europe PMC12
2018 Ng, H. S., Koczwara, B., Roder, D., & Vitry, A. (2018). Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study. Prostate cancer and prostatic diseases, 21(3), 403-410.
DOI Scopus47 WoS46 Europe PMC40
2018 Hillen, J. B., Vitry, A., & Caughey, G. E. (2018). Medication-related quality of care in residential aged care: an Australian experience.. International journal for quality in health care : journal of the International Society for Quality in Health Care, 31(4), 298-306.
DOI Scopus11 WoS10 Europe PMC8
2018 Thai, L. P., Vitry, A. I., & Moss, J. R. (2018). Price and utilisation differences for statins between four countries. Expert review of pharmacoeconomics and outcomes research, 18(1), 71-81.
DOI Scopus5 WoS3 Europe PMC4
2018 Ng, H. S., Koczwara, B., Roder, D. M., Niyonsenga, T., & Vitry, A. I. (2018). Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis. Medical Journal of Australia, 208(1), 24-28.
DOI Scopus20 WoS19 Europe PMC18
2018 Ng, H. S., Koczwara, B., Roder, D., & Vitry, A. (2018). Changes in the prevalence of comorbidity in the Australian population with cancer, 2007-2014. Cancer epidemiology, 54, 56-62.
DOI Scopus12 WoS11 Europe PMC8
2018 Ng, H. S., Roder, D., Koczwara, B., & Vitry, A. (2018). Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study.. Asia-Pacific journal of clinical oncology, 14(2), e181-e192.
DOI Scopus59 WoS51 Europe PMC47
2017 Caughey, G., Tait, K., Vitry, A., & Shakib, S. (2017). Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity. Patient Preference and Adherence, 11, 131-140.
DOI Scopus23 WoS21 Europe PMC16
2017 Wang, H., Sun, Q., Vitry, A., & Nguyen, T. A. (2017). Availability, prices and affordability of selected essential medicines for chronic diseases in 11 countries of the Asia Pacific Region: a secondary analysis. Asia Pacific journal of public health, 29(4), 268-277.
DOI Scopus20 Europe PMC16
2017 Hopkins, A., Vitry, A., O'Doherty, C., Proudman, S., & Wiese, M. (2017). Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide. International Journal of Rheumatic Diseases, 20(11), 1795-1797.
DOI Scopus1 WoS1 Europe PMC1
2017 Hillen, J., Vitry, A., & Caughey, G. (2017). Disease burden, comorbidity and geriatric syndromes in the Australian aged care population. Australasian Journal on Ageing, 36(2), 14-19.
DOI Scopus38 WoS37 Europe PMC30
2017 Hillen, J., Vitry, A., & Caughey, G. (2017). Evaluating medication-related quality of care in Australian aged care: A role for collaborative health services. Journal of Pharmacy Practice and Research, 47(1), 63-66.
DOI Scopus3
2016 Hillen, J., Vitry, A., & Caughey, G. (2016). Trends in general practitioner services to residents in aged care. Australian Journal of Primary Health, 22(6), 517-522.
DOI Scopus11 WoS11 Europe PMC8
2016 Thai, L., Moss, J., Godman, B., & Vitry, A. (2016). Cost driver analysis of statin expenditure on Australia’s Pharmaceutical Benefits Scheme. Expert Review of Pharmacoeconomics and Outcomes Research, 16(3), 419-433.
DOI Scopus5 WoS4 Europe PMC3
2016 Hopkins, A., Proudman, S., Vitry, A., Sorich, M., Cleland, L., & Wiese, M. (2016). Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia. Medical Journal of Australia, 204(2), 64-68.e1.
DOI Scopus16 WoS14 Europe PMC9
2016 Tan, E., Visvanathan, R., Hilmer, S., Vitry, A., Emery, T., Robson, L., . . . Bell, J. (2016). Analgesic use and pain in residents with and without dementia in aged care facilities: a cross-sectional study. Australasian Journal on Ageing, 35(3), 180-187.
DOI Scopus35 WoS34 Europe PMC27
2016 Thai, L., Vitry, A., & Moss, J. (2016). Pricing and utilisation of proton pump inhibitors in South Australian public hospitals and the Pharmaceutical Benefits Scheme. Journal of Pharmacy Practice and Research, 46(2), 130-136.
DOI Scopus2
2016 Caughey, G., Vitry, A., Ramsay, E., Gilbert, A., Shakib, S., Ryan, P., . . . Roughead, E. (2016). Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes. Internal Medicine Journal, 46(12), 1430-1436.
DOI Scopus13 WoS15 Europe PMC11
2016 Vogler, S., Vitry, A. I., & Babar, Z. U. D. (2016). Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study. Lancet oncology, 17(1), 39-47.
DOI
2016 Vitry, A. (2016). Transparency is good, independence from pharmaceutical industry is better!. Australian Prescriber, 39(4), 112-113.
DOI
2016 Vitry, A., Mintzes, B., & Lipworth, W. (2016). Access to new cancer medicines in Australia: dispelling the myths and informing a public debate. Journal of pharmaceutical policy and practice, 9(13), 1-6.
DOI
2015 Godman, B., Wilcock, M., Martin, A., Bryson, S., Vitry, A. I., & Malmström, R. E. (2015). Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future. Generics and biosimilars initiative journal, 4(3), 125-135.
DOI
2015 Vitry, A., Nguyen, T., Entwistle, V., & Roughead, E. (2015). Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study. Journal of Pharmaceutical Policy and Practice, 8(25), 1-11.
DOI Scopus44 Europe PMC26
2015 Vitry, A. (2015). Approval, reimbursement and pricing of high-cost cancer medicines in Australia. Journal of Pharmaceutical Policy and Practice, 8(1), 1.
DOI
2015 Othman, N., Vitry, A. I., Roughead, E. E., Ismail, S. B., & Omar, K. (2015). Doctors' views on the quality of claims provided by pharmaceutical representatives: a comparative study in Malaysia and Australia. Journal of Taibah University Medical Sciences, 10(4), 471-480.
DOI Scopus4 WoS4
2015 Hillen, J., Vitry, A., & Caughey, G. (2015). Evaluating medication-related quality of care in residential aged care: a systematic review. SpringerPlus, 4(1), 17 pages.
DOI Scopus20 WoS16 Europe PMC16
2015 Tan, E., Visvanathan, R., Hilmer, S., Emery, T., Robson, L., Vitry, A., . . . Bell, J. (2015). Analgesic use and daytime sleepiness in residents with and without dementia in residential aged care facilities. Drugs and Aging, 32(12), 1045-1053.
DOI Scopus13 WoS12 Europe PMC11
2015 Gabb, G., Vitry, A., & Thynne, T. (2015). Data informs debate. Australian Prescriber, 38(4), 113-114.
DOI
2015 Gabb, G., Vitry, A., & Thynne, T. (2015). Letters. Australian Prescriber, 38(4), 114.
DOI
2015 Gabb, G., Vitry, A., & Thynne, T. (2015). Data informs debate. Australian Prescriber, 38(4), 113-114.
DOI
2014 Tan, E., Visvanathan, R., Hilmer, S., Vitry, A., Quirke, T., Emery, T., . . . Bell, J. (2014). Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol. BMJ Open, 4(6), 1-6.
DOI Scopus32 WoS34 Europe PMC26
2014 Thai, L., Vitry, A., & Moss, J. (2014). Discounting of medicines in Australian community pharmacies. Australian Health Review, 38(5), 517-522.
DOI Scopus2 WoS1 Europe PMC1
2014 Vitry, A., Nguyen, T., Ramsay, E., Caughey, G., Gilbert, A., Shakib, S., . . . Roughead, E. (2014). General practitioner management plans delaying time to next potentially preventable hospitalisation for patients with heart failure. Internal Medicine Journal, 44(11), 1117-1123.
DOI Scopus17 WoS14 Europe PMC17
2014 Vitry, A., & Roughead, E. (2014). Managed entry agreements for pharmaceuticals in Australia. Health policy, 117(3), 345-352.
DOI
2014 Kelly, E., Lu, C. Y., Albertini, S., & Vitry, A. (2014). Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison. Journal of clinical pharmacy and therapeutics, 40(1), 76-82.
DOI Scopus22 WoS20 Europe PMC17
2014 Babar, Z. U. D., & Vitry, A. I. (2014). Differences in Australian and New Zealand medicines funding policies. Australian prescriber, 37(5), 150-151.
DOI
2013 Gabb, G., & Vitry, A. (2013). Serious statin associated myotoxicity (SSAM) in Aboriginal and Torres Strait Islanders. Heart, Lung and Circulation, 22(S1 254), S254.
DOI
2013 Gabb, G., Vitry, A., Limaye, V., & Alhami, G. (2013). Serious statin-associated myotoxicity and rhabdomyolysis in aboriginal and torres strait islanders: A case series. Internal Medicine Journal, 43(9), 987-992.
DOI Scopus17 WoS15 Europe PMC12
2013 Caughey, G., Preiss, A., Vitry, A., Gilbert, A., Ryan, P., Shakib, S., . . . Roughead, E. (2013). Does antidepressant medication use affect persistence with diabetes medicines?. Pharmacoepidemiology and Drug Safety, 22(6), 615-622.
DOI Scopus16 WoS15 Europe PMC13
2013 Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2013). Comorbid diabetes and copd: impact of corticosteroid use on diabetes complications. Diabetes Care, 36(10), 3009-3014.
DOI Scopus55 WoS51 Europe PMC45
2012 Vitry, A., Roughead, E., Ramsay, E., Ryan, P., Caughey, G., Esterman, A., . . . McDermott, R. (2012). Chronic disease management: Does the disease affect likelihood of care planning?. Australian Health Review, 36(4), 419-423.
DOI Scopus9 WoS10 Europe PMC7
2012 Vitry, A. I., & Mintzes, B. (2012). Disease mongering and low testosterone in men: the tale of two regulatory failures. Medical journal of Australia, 196(10), 619-621.
DOI
2012 Baumgärtel, C., Godman, B., Malmstrom, R. E., Andersen, M., Vitry, A. I., & Gustafsson, L. L. (2012). What lessons can be learned from the launch of generic clopidogrel?. Generics and Biosimilars Initiative, 1(2), 58-68.
DOI
2012 Godman, B., Abuelkhair, M., Vitry, A., Abdu, S., Bennie, M., Bishop, I., . . . Gustaffson, L. (2012). Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach. Generics and biosimilars initiative, 1(2), 69-83.
DOI
2012 Lexchin, J., & Vitry, A. I. (2012). Should the C in CME Stand for Commercial?. Southern med review, 5(1), 3-5.
2011 Vitry, A., Thai, L. P., & Lu, C. Y. (2011). Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia. Internal medicine journal, 41(2), 162-166.
DOI Scopus10 WoS9 Europe PMC8
2011 Lu, C. Y., Barratt, J., Vitry, A., & Roughead, E. (2011). Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. Journal of clinical epidemiology, 64(2), 223-228.
DOI Scopus88 Europe PMC76
2011 Vitry, A., Roughead, E., Ramsay, E., Preiss, A., Ryan, P., Gilbert, A., . . . McDermott, R. (2011). Major bleeding risk associated with warfarin and co-medications in the elderly population. Pharmacoepidemiology and Drug Safety, 20(10), 1057-1063.
DOI Scopus52 WoS45 Europe PMC40
2011 Gilbert, A., Caughey, G., Vitry, A., Clark, A., Ryan, P., McDermott, R., . . . Roughead, E. (2011). Ageing well: Improving the management of patients with multiple chronic health problems. Australasian Journal on Ageing, 30(Suppl 2), 32-37.
DOI Scopus17 WoS18 Europe PMC15
2011 Caughey, G., Roughead, E., Shakib, S., Vitry, A., & Gilbert, A. (2011). Co-morbidity and potential treatment conflicts in elderly heart failure patients: A retrospective, cross-sectional study of administrative claims data. Drugs and Aging, 28(7), 575-581.
DOI Scopus36 WoS25 Europe PMC30
2011 Zhang, Y., Vitry, A., Caughey, G., Roughead, E., Ryan, P., Gilbert, A., . . . McDermott, R. (2011). The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes. Diabetes Research and Clinical Practice, 91(1), 115-120.
DOI Scopus5 WoS4 Europe PMC4
2011 Roughead, E. E., Vitry, A. I., Caughey, G. E., & Gilbert, A. L. (2011). Multimorbidity, care complexity and prescribing for the elderly. Aging health, 7(5), 695-705.
DOI Scopus47
2010 Vitry, A. I., Hoile, A. P., Gilbert, A. L., Esterman, A., & Luszcz, M. A. (2010). The risk of falls and fractures associated with persistent use of psychotropic medications in elderly people. Archives of gerontology and geriatrics, 50(3), e1-e4.
DOI Scopus23 WoS16 Europe PMC15
2010 Caughey, G., Roughead, E., Shakib, S., McDermott, R., Vitry, A., & Gilbert, A. (2010). Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age and Ageing, 39(4), 488-494.
DOI Scopus47 WoS41 Europe PMC35
2010 Vitry, A., Roughead, E., Preiss, A., Ryan, P., Ramsay, E., Gilbert, A., . . . McDermott, R. (2010). Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study. PLoS One, 5(11), 1-5.
DOI Scopus34 WoS32 Europe PMC27
2010 Spurling, G., Mansfield, P., Montgomery, B., Lexchin, J., Doust, J., Othman, N., & Vitry, A. (2010). Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Medicine, 7(10), 1-22.
DOI Scopus397 WoS331 Europe PMC266
2010 Caughey, G., Roughead, E., Pratt, N., Shakib, S., Vitry, A., & Gilbert, A. (2010). Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?. Pharmacoepidemiology and Drug Safety, 19(9), 977-982.
DOI Scopus62 WoS57 Europe PMC45
2010 Sorich, M., Vitry, A., Ward, M., Horowitz, J., & McKinnon, R. (2010). Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data. Journal of Thrombosis and Haemostasis, 8(8), 1678-1684.
DOI Scopus95 WoS79 Europe PMC73
2010 Zhang, Y., Chow, V., Vitry, A., Ryan, P., Roughead, E., Caughey, G., . . . Luszcz, M. (2010). Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing. International Psychogeriatrics, 22(3), 437-444.
DOI Scopus22 WoS22 Europe PMC21
2010 Zhang, Y., Vitry, A., Roughead, E., Ryan, P., & Gilbert, A. (2010). Co-morbidity and the utilization of health care for Australian veterans with diabetes. Diabetic Medicine, 27(1), 65-71.
DOI Scopus15 WoS10 Europe PMC7
2010 Roughead, E., Vitry, A., Preiss, A., Barratt, J., Gilbert, A., & Ryan, P. (2010). Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease. European Journal of Cardiovascular Prevention ' Rehabilitation, 17(1), 71-76.
DOI Scopus13 WoS13 Europe PMC11
2010 Caughey, G., Roughead, E., Vitry, A., McDermott, R., Shakib, S., & Gilbert, A. (2010). Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Research and Clinical Practice, 87(3), 385-393.
DOI Scopus161 WoS144 Europe PMC128
2010 Caughey, G., Ramsay, E., Vitry, A., Gilbert, A., Luszcz, M., Ryan, P., & Roughead, E. (2010). Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. Journal of Epidemiology and Community Health, 64(12), 1036-1042.
DOI Scopus77 WoS66 Europe PMC69
2010 Vitry, A. I., Roughead, E. E., Ramsay, E. N., Preiss, A. K., Caughey, G. E., Gilbert, A. L., & Ryan, P. (2010). Major Bleeding Risk Associated with Warfarin and Co-Medications in the Elderly Population. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 19, S132.
2010 Othman, N., Vitry, A. I., Roughead, E. E., Ismail, S. B., & Omar, K. (2010). Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia. BMC public health, 10(743), 1-11.
DOI Scopus29 WoS18 Europe PMC22
2010 Vitry, A. I. (2010). The imperative of happiness for women living with breast cancer. Canadian women studies, 28(2-3), 30-33.
2010 Othman, N., Vitry, A. I., & Roughead, E. E. (2010). Quality of claims, references and the presentation of risk results in medical journal advertising : a comparative study in Australia, Malaysia and the United States. BMC public health, 10(1), article no. 294.
DOI
2010 Othman, N., Vitry, A. I., & Roughead, E. E. (2010). Medicines information in medical journal advertising in Australia, Malaysia and the United States : a comparative cross-sectional study. Southern Med Review, 3(1), 11-18.
2010 Vitry, A. I. (2010). Reporting of studies on new medicines in major medical journals : a case study in breast cancer. Clinical pharmacology and therapeutics, 87(4), 398-400.
DOI
2009 Thomas, R., & Vitry, A. (2009). Consumers' perceptions of generic medicines in community pharmacies in Malaysia. Southern med review, 2(2), 20-23.
2009 Vitry, A., & Lai, Y. H. (2009). Advertising of antihypertensive medicines and prescription sales in Australia. Internal medicine journal, 39(11), 728-732.
DOI
2009 Othman, N., Vitry, A., & Roughead, E. E. (2009). Quality of pharmaceutical advertisements in medical journals : a systematic review. PLoS one, 4(7, article no. e6350), 1-11.
DOI
2009 Vitry, A. I. (2009). Written medicine information in Australia, answer to the letter to the editor. Pharmacy world and science, 31(6), 605-606.
DOI
2009 Vitry, A. I. (2009). Does Direct-to-Consumer Prescription Drug Advertising Do More Harm Than Good?. Annals of internal medicine, 151(11), 823-824.
2009 Vitry, A. I., Bertele, V., & Garattinii, S. (2009). Drug regulations and the need for greater transparency. Regulatory affairs journal pharma, March, 143-146.
2009 Vitry, A., Gilbert, A., Mott, K., Rao, D., & March, G. (2009). Provision of medicines information in Australian community pharmacies. Pharmacy world and science, 31(2), 154-157.
DOI
2009 Vitry, A., Wong, S., Roughead, E., Ramsay, E., & Barratt, J. (2009). Validity of medication-based co-morbidity indices in the Australian elderly population. Australian and New Zealand Journal of Public Health, 33(2), 126-130.
DOI Scopus94 WoS89 Europe PMC77
2009 Goh, L. Y., Vitry, A. I., Semple, S. J., Esterman, A., & Luszcz, M. A. (2009). Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population. BMC complementary and alternative medicine, 9, article no. 42(9), 10-11.
DOI Scopus102 WoS86 Europe PMC66
2008 Caughey, G. E., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2008). Prevalence of comorbidity of chronic diseases in Australia. BMC public health, 8(1), article no. 221.
DOI Scopus180 WoS155 Europe PMC133
2008 Vitry, A., & Zhang, Y. (2008). Quality of Australian clinical guidelines and relevance to the care of older people with multiple morbid conditions. Medical Journal of Australia, 189(7), 360-365.
DOI Scopus80 WoS61 Europe PMC57
2008 Roughead, E. E., Gilbert, A. L., & Vitry, A. I. (2008). The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy. Health Policy, 88(2-3), 250-257.
DOI
2008 Vitry, A. I., Lexchin, J., Sasich, L., Dupin Spriet, T., Reed, T., Bertele, V., . . . Hurley, E. (2008). Provision of information on regulatory authorities' websites. Internal medicine journal, 38(7), 559-567.
DOI
2008 Vitry, A. I., Phillips, S., & Semple, S. J. (2008). Quality and availability of consumer information on heart failure in Australia. BMC health services research, 8(1), article no. 255.
DOI
2008 Vitry, A. I. (2008). Time for transparency at the TGA. Australian prescriber, 31(5), 114-115.
2007 Vitry, A. I., Mintzes, B., & Lexchin, J. (2007). Direct-to-consumer advertising policy in Australia: realism in whose interests?. Royal Australiasian College of Physicians -Journal compilation, 37(9), 665-666.
DOI
2007 Vitry, A. I. (2007). Comparative assessment of four drug interaction compendia. British Journal of Clinical Pharmacology, 63(6), 709-714.
DOI
2007 Vitry, A., Lexchin, J., & Mansfield, P. (2007). Is Australia's national medicines policy failing? The case of COX-2 inhibitors. International Journal of Health Services, 37(4), 735-744.
DOI Scopus2 WoS5 Europe PMC1
2005 Mansfield, P., Vitry, A., & Wright, J. (2005). Withdraw all COX-2-selective drugs. Medical Journal of Australia, 182(4), 197.
DOI Scopus3 WoS3 Europe PMC1
2005 Mansfield, P. (2005). Rofecoxib withdrawal. Australian Prescriber, 28(2), 30.
2005 Roughead, E. E., Semple, S. J., & Vitry, A. I. (2005). Pharmaceutical care services: a systemic review of published studies 1990 to 2003, examining effectiveness in improving patient outcomes. International journal of pharmacy practice, 13(1), 53-70.
DOI
2005 Harvey, K., Vitry, A. I., Roughead, E. E., Aroni, R., Ballenden, N., & Faggotter, R. (2005). Pharmaceutical advertisements in prescribing software. Medical journal of Australia.
2004 Vitry, A. I. (2004). Is Australia free from direct-to-consumer advertising?. Australian Prescriber.
2003 Vitry, A. I. (2003). And next: a flask of wine for Daddy? [letter]. Australian prescriber, 26(5), 102.
DOI
2003 López-Gil, A., Peiró, S., Librero, J., Villanueva, P., Pereiró, I., Simmonds, H., . . . Ferner, R. E. (2003). Drug advertising in medical journals [2] (multiple letters). Lancet, 361(9360), 877-878.
DOI WoS1 Europe PMC1
2002 Vitry, A. I., Corbillon, E., & Pouillie, A. (2002). Usefulness of virtual colonoscopy in colorectal cancer detection. Acta endoscopica.
1999 Gabb, G., & Vitry, A. (1999). Electronic prescribing [1]. Australian Prescriber, 22(2), 28.
1999 Gabb, G., & Vitry, A. (1999). Choosing between old and new drugs [5]. Australian Prescriber, 22(1), 5.

Year Citation
2014 Hillen, J., Vitry, A., & Caughey, G. (2014). Epidemiology of disease, medication use and health service utilisation in Australian residential aged care. Implications for evaluating medication-related quality of care. In Making Research Matter: 13th National Conference of Emerging Researchers in Ageing Program & Proceedings (pp. 76-83). Australia: Flinders University.
2012 Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2012). Antidepressants and Risk of Discontinuation of Diabetes Medicines. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 188). WILEY PERIODICALS, INC.
2012 Vitry, A. I., Eeow, Z. H., & Caughey, G. E. (2012). International Comparison of the Utilisation of Anti-Diabetic Medicines. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 163-164). WILEY PERIODICALS, INC.
2011 Vitry, A. (2011). Low use of care plans for the management of chronic diseases in the Australian Veteran population. In Ninth Asia/Oceania Regional Congress of Gerontology and Geriatrics. Australia.
2010 Vitry, A. I., Thai, L., & Lu, C. (2010). Utilisation of Endocrine Therapy in Women with Breast Cancer in Australia. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 19 (pp. S241). ENGLAND, Brighton: WILEY-BLACKWELL.
2010 Caughey, G., Roughead, E., Pratt, N., Shakib, S., Vitry, A., & Gilbert, A. (2010). Adverse Outcomes Associated with Potential Prescribing Cascades. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 19 (pp. S130-S131). Brighton, ENGLAND: WILEY-BLACKWELL.
2009 Caughey, G., Vitry, A., Gilbert, A., & Roughead, E. (2009). Polypharmacy in Chronic Diseases in the Elderly: Evidence-Based or Potentially Inappropriate Prescribing?. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 18 (pp. S197-S198). JOHN WILEY & SONS LTD.
2009 Vitry, A., Roughead, E., Ramsay, E., Preiss, K., Ryan, P., Esterman, A., . . . Caughey, G. (2009). Risk in older patients of major bleeding associated with warfarin when other medicines are co-prescribed for concomitant medical conditions. In AUSTRALASIAN JOURNAL ON AGEING Vol. 28 (pp. A119). WILEY-BLACKWELL PUBLISHING, INC.
2008 Zhang, Y., Vitry, A., Chow, V., & Caughey, G. E. (2008). Antidepressant use among the Australian elderly: A longitudinal study. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 17 (pp. S91-S92). WILEY-BLACKWELL.
2008 Vitry, A. I., Wong, S. A., Roughead, E. E., & Ramsay, E. (2008). Validity of medication-based comorbidity indices in the Australian elderly population. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 17 (pp. S88). JOHN WILEY & SONS LTD.
2005 Angley, M. T., Avent, M., Gilbert, A. L., Hotham, E. D., March, G. J., Soulsby, N. R., . . . Vitry, A. I. (2005). Problem based learning 'filling the gaps' in pharmacy education. In Annual Conference in Conjuction with APFM. Auckland, New Zealand: ANZAME.

Year Citation
2016 Nguyen, T. A., Qiang, S., Wang, H., Undela, K., & Vitry, A. (2016). Availability and prices of essential medicines for chronic diseases in the Asia Pacific Region: a secondary analysis. Poster session presented at the meeting of International Journal of Pharmacy Practice. UK: Wiley.
2016 Ng, H. S., Roder, D., & Vitry, A. (2016). Prevalence of comorbidities and health status among current cancer and cancer survivors: an Australian-based study. Poster session presented at the meeting of Value in health. US: Elsevier.
DOI
2015 Hopkins, A., Proudman, S., Vitry, A., Sorich, M., Cleland, L., & Wiese, M. (2015). WHAT HAVE WE LEARNT FROM 10 YEARS OF BIOLOGICAL DISEASE MODIFYING AGENTS ON THE PHARMACEUTICAL BENEFIT SCHEME?. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
2015 Nguyen, T. A., Qiang, S., Wang, H., Undela, K., & Vitry, A. (2015). Availability and prices of essential medicines for chronic diseases in older people in the Asia Pacific Region. Poster session presented at the meeting of Journal of pharmaceutical policy and practice. UK: BioMed Central.
DOI
2013 Thomas, J. S., Vitry, A., & Marker, J. (2013). STUDENT PERCEPTIONS OF A CONSUMER LED DISCUSSION GROUP FORMAT TO IMPROVE AWARENESS OF THE PATIENT PERSPECTIVE. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL.
2012 Godman, B., Baumgaertel, C., Skiold, P., Bishop, I., Abuelkhair, M., Burkhardt, T., . . . Zara, C. (2012). Enhancing the utilisation of generic clopidogrel: implications for future efficiency meetings. Poster session presented at the meeting of 9th HTAi Annual Meeting: HTA in Integrated Care for a Patient Centered System. Spain: Elsevier.
2011 Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2011). Increased risk of hospitalisation with corticosteroid use in patients with diabetes and COPD. Poster session presented at the meeting of Pharmacoepidemiology and drug safety. UK: WILEY-BLACKWELL.
2008 Caughey, G., Vitry, A., Gilbert, A., & Roughead, E. E. (2008). Concomitant chronic medication prescribing in the elderly. Poster session presented at the meeting of National Medicines Symposium 2008. Australia.

  • Socio-cultural Factors and the Use of Therapeutic Opioids in Indonesia.
			, ARC - Linkage Project, 26/06/2023 - 25/06/2026

  • Optimization and validation of assay of French protocol for phenotyping patient samples for treatment optimization, Pari-Passou Medical Consultancy, 03/08/2020 - 31/12/2020

  • Evaluation of risks and potential impact of scheduling of ketamine on access on low and middle income countries, World Health Organisation Malaysia, 01/01/2016 - 30/12/2017

Connect With Me

External Profiles

Other Links